{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T06:15:15Z","timestamp":1790316915605,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T00:00:00Z","timestamp":1692403200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["821528"],"award-info":[{"award-number":["821528"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013322","name":"European Federation of Pharmaceutical Industries and Associations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological and Toxicological Methods"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.vascn.2023.107281","type":"journal-article","created":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T21:12:16Z","timestamp":1687986736000},"page":"107281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Comparative assessment of Ca2+ oscillations in 2- and 3-dimensional hiPSC derived and isolated cortical neuronal networks"],"prefix":"10.1016","volume":"123","author":[{"given":"John P.","family":"Imredy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautier","family":"Roussignol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Clouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Salvagiotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludmilla","family":"Mazelin-Winum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vascn.2023.107281_bb0005","first-page":"11402","article-title":"Interpreting in vivo calcium signals from neuronal cell bodies, axons, and dendrites: A review","volume":"7","author":"Ali","year":"2020","journal-title":"Neurophotonics"},{"key":"10.1016\/j.vascn.2023.107281_bb0010","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1007\/s00204-020-02788-1","article-title":"Molecular basis of mood and cognitive adverse events elucidated via a combination of pharmacovigilance data mining and functional enrichment analysis","volume":"94","author":"Andronis","year":"2020","journal-title":"Archives of Toxicology"},{"key":"10.1016\/j.vascn.2023.107281_bb0015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.neurobiolaging.2019.01.014","article-title":"Acute treatment with the PDE4 inhibitor roflumilast improves verbal word memory in healthy old individuals: A double-blind placebo-controlled study","volume":"77","author":"Blokland","year":"2019","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.vascn.2023.107281_bb0020","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.slasd.2022.01.003","article-title":"A multiparametric calcium signal screening platform using iPSC-derived cortical neural spheroids","volume":"27","author":"Boutin","year":"2022","journal-title":"SLAS Discovery"},{"key":"10.1016\/j.vascn.2023.107281_bb0025","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/toxsci\/kfy029","article-title":"In vitro screening for seizure liability using microelectrode array technology","volume":"163","author":"Bradley","year":"2018","journal-title":"Toxicological Sciences"},{"key":"10.1016\/j.vascn.2023.107281_bb0030","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1016\/j.toxlet.2022.07.239","article-title":"The NeuroDeRisk toolbox: DeRisking chemical structures for neurotoxic adverse outcomes","volume":"368","author":"Bryant","year":"2022","journal-title":"Toxicology Letters"},{"key":"10.1016\/j.vascn.2023.107281_bb0035","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.scr.2017.10.010","article-title":"Comparison of 2D and 3D neural induction methods for the generation of neural progenitor cells from human induced pluripotent stem cells","volume":"25","author":"Chandrasekaran","year":"2017","journal-title":"Stem Cell Research"},{"key":"10.1016\/j.vascn.2023.107281_bb0040","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.celrep.2016.02.090","article-title":"mTORC1 inhibition corrects neurodevelopmental and synaptic alterations in a human stem cell model of tuberous sclerosis","volume":"15","author":"Costa","year":"2016","journal-title":"Cell Reports"},{"key":"10.1016\/j.vascn.2023.107281_bb0045","doi-asserted-by":"crossref","first-page":"21590","DOI":"10.1038\/s41598-021-00939-7","article-title":"Developmental defects and impaired network excitability in a cerebral organoid model of KCNJ11 p.V59M-related neonatal diabetes","volume":"11","author":"Dalgin","year":"2021","journal-title":"Scientific Reports"},{"key":"10.1016\/j.vascn.2023.107281_bb0050","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.brainres.2004.01.059","article-title":"Spontaneous synchronized calcium oscillations in neocortical neurons in the presence of physiological [Mg2+]: Involvement of AMPA\/kainate and metabotropic glutamate receptors","volume":"1006","author":"Dravid","year":"2004","journal-title":"Brain Research"},{"key":"10.1016\/j.vascn.2023.107281_bb0055","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.drudis.2009.06.003","article-title":"Approaches to seizure risk assessment in preclinical drug discovery","volume":"14","author":"Easter","year":"2009","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.vascn.2023.107281_bb0065","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jphs.2017.01.003","article-title":"Machine learning-based prediction of adverse drug effects: An example of seizure-inducing compounds","volume":"133","author":"Gao","year":"2017","journal-title":"Journal of Pharmacological Sciences"},{"key":"10.1016\/j.vascn.2023.107281_bb0070","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/toxsci\/kfab116","article-title":"Principal component analysis to distinguish seizure liability of drugs in human iPS cell-derived neurons","volume":"184","author":"Ishibashi","year":"2021","journal-title":"Toxicological Sciences"},{"key":"10.1016\/j.vascn.2023.107281_bb0075","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.tox.2017.06.010","article-title":"Human induced pluripotent stem cell (hiPSC)-derived neurons respond to convulsant drugs when co-cultured with hiPSC-derived astrocytes","volume":"389","author":"Ishii","year":"2017","journal-title":"Toxicology"},{"key":"10.1016\/j.vascn.2023.107281_bb0080","doi-asserted-by":"crossref","first-page":"eabn4705","DOI":"10.1126\/science.abn4705","article-title":"Mitochondria metabolism sets the species-specific tempo of neuronal development","volume":"379","author":"Iwata","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.vascn.2023.107281_bb0085","article-title":"Human in vitro models of epilepsy using embryonic and induced pluripotent stem cells","volume":"11","author":"Javaid","year":"2022","journal-title":"Cells-Basel."},{"key":"10.1016\/j.vascn.2023.107281_bb0090","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0304-3940(96)12448-4","article-title":"Spontaneous periodic synchronized bursting during formation of mature patterns of connections in cortical cultures","volume":"206","author":"Kamioka","year":"1996","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.vascn.2023.107281_bb0095","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2131\/jts.39.579","article-title":"Establishment of a novel experimental protocol for drug-induced seizure liability screening based on a locomotor activity assay in zebrafish","volume":"39","author":"Koseki","year":"2014","journal-title":"The Journal of Toxicological Sciences"},{"key":"10.1016\/j.vascn.2023.107281_bb0100","doi-asserted-by":"crossref","first-page":"36529","DOI":"10.1038\/srep36529","article-title":"Sustained synchronized neuronal network activity in a human astrocyte co-culture system","volume":"6","author":"Kuijlaars","year":"2016","journal-title":"Scientific Reports"},{"key":"10.1016\/j.vascn.2023.107281_bb0105","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.seizure.2009.11.005","article-title":"Seizure risk associated with neuroactive drugs: Data from the WHO adverse drug reactions database","volume":"19","author":"Kumlien","year":"2010","journal-title":"Seizure"},{"key":"10.1016\/j.vascn.2023.107281_bb0110","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/s42003-022-04177-z","article-title":"High throughput 3D gel-based neural organotypic model for cellular assays using fluorescence biosensors","volume":"5","author":"Kundu","year":"2022","journal-title":"Communications Biology"},{"key":"10.1016\/j.vascn.2023.107281_bb0115","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1016\/j.neubiorev.2013.10.011","article-title":"The kainic acid model of temporal lobe epilepsy","volume":"37","author":"Levesque","year":"2013","journal-title":"Neuroscience and Biobehavioral Reviews"},{"key":"10.1016\/j.vascn.2023.107281_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.690147","article-title":"Using genetically encoded calcium indicators to study astrocyte physiology: A field guide","volume":"15","author":"Lohr","year":"2021","journal-title":"Frontiers in Cellular Neuroscience"},{"key":"10.1016\/j.vascn.2023.107281_bb0125","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.cell.2010.10.016","article-title":"A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells","volume":"143","author":"Marchetto","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.vascn.2023.107281_bb0130","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1523\/JNEUROSCI.12-12-04834.1992","article-title":"Spontaneous synchronous synaptic calcium transients in cultured cortical-neurons","volume":"12","author":"Murphy","year":"1992","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.vascn.2023.107281_bb0135","author":"NeuroDeRisk"},{"key":"10.1016\/j.vascn.2023.107281_bb0140","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1177\/1535759720949254","article-title":"Human brain organoid models of developmental epilepsies","volume":"20","author":"Nieto-Estevez","year":"2020","journal-title":"Epilepsy Currents"},{"key":"10.1016\/j.vascn.2023.107281_bb0145","doi-asserted-by":"crossref","first-page":"26181","DOI":"10.1038\/srep26181","article-title":"Physiological maturation and drug responses of human induced pluripotent stem cell-derived cortical neuronal networks in long-term culture","volume":"6","author":"Odawara","year":"2016","journal-title":"Scientific Reports"},{"key":"10.1016\/j.vascn.2023.107281_bb0150","first-page":"45","article-title":"New in vitro phenotypic assays for epilepsy: Fluorescent measurement of synchronized neuronal calcium oscillations","volume":"54","author":"Pacico","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.vascn.2023.107281_bb0155","doi-asserted-by":"crossref","first-page":"e84755","DOI":"10.1371\/journal.pone.0084755","article-title":"New in vitro phenotypic assay for epilepsy: Fluorescent measurement of synchronized neuronal calcium oscillations","volume":"9","author":"Pacico","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.vascn.2023.107281_bb0160","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0076-6879(06)14019-7","article-title":"Measurement and analysis of calcium signaling in heterogeneous cell cultures","volume":"414","author":"Richards","year":"2006","journal-title":"Methods in Enzymology"},{"key":"10.1016\/j.vascn.2023.107281_bb0165","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1039\/c9tx00210c","article-title":"Innovative models for in vitro detection of seizure","volume":"8","author":"Rockley","year":"2019","journal-title":"Toxicology Research"},{"key":"10.1016\/j.vascn.2023.107281_bb0170","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.vascn.2017.09.210","article-title":"Neuronal calcium oscillations for preclinical seizure risk evaluation","volume":"88","author":"Roussignol","year":"2017","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2023.107281_bb0175","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1586\/14737175.6.4.575","article-title":"Epileptogenic drugs: A systematic review","volume":"6","author":"Ruffmann","year":"2006","journal-title":"Expert Review of Neurotherapeutics"},{"key":"10.1016\/j.vascn.2023.107281_bb0180","doi-asserted-by":"crossref","first-page":"780","DOI":"10.2174\/1389201020666191129103730","article-title":"Approach to neurotoxicity using human iPSC neurons: Consortium for safety assessment using human iPS cells","volume":"21","author":"Shirakawa","year":"2020","journal-title":"Current Pharmaceutical Biotechnology"},{"key":"10.1016\/j.vascn.2023.107281_bb0185","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/toxsci\/kfy218","article-title":"Functional and mechanistic neurotoxicity profiling using human iPSC-derived neural 3D cultures","volume":"167","author":"Sirenko","year":"2019","journal-title":"Toxicological Sciences"},{"key":"10.1016\/j.vascn.2023.107281_bb0190","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.3390\/ijms22041908","article-title":"Human iPSC-derived 2D and 3D platforms for rapidly assessing developmental, functional, and terminal toxicities in neural cells","volume":"22","author":"Slavin","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.vascn.2023.107281_bb0195","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00204-017-2035-5","article-title":"Screening the ToxCast phase II libraries for alterations in network function using cortical neurons grown on multi-well microelectrode array (mwMEA) plates","volume":"92","author":"Strickland","year":"2018","journal-title":"Archives of Toxicology"},{"key":"10.1016\/j.vascn.2023.107281_bb0200","doi-asserted-by":"crossref","unstructured":"Strong, C.E., Kundu, S., Boutin, M., Chen, Y.-C., Wilson, K., Lee, E., & Ferrer, M. (2022). Functional brain region-specific neural spheroids for modeling neurological diseases and therapeutics screening. bioRxiv, 2022.05.04, 490442.","DOI":"10.1101\/2022.05.04.490442"},{"key":"10.1016\/j.vascn.2023.107281_bb0205","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1038\/s41380-018-0018-4","article-title":"Purkinje cells derived from TSC patients display hypoexcitability and synaptic deficits associated with reduced FMRP levels and reversed by rapamycin","volume":"23","author":"Sundberg","year":"2018","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.vascn.2023.107281_bb0210","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/stem.2203","article-title":"Concise review: Exciting cells: Modeling genetic epilepsies with patient-derived induced pluripotent stem cells","volume":"34","author":"Tidball","year":"2016","journal-title":"Stem Cells"},{"key":"10.1016\/j.vascn.2023.107281_bb0215","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/toxsci\/kfaa136","article-title":"Applicability of hiPSC-derived neuronal cocultures and rodent primary cortical cultures for in vitro seizure Liabiliy assessment","volume":"178","author":"Tukker","year":"2020","journal-title":"Toxicological Sciences"},{"key":"10.1016\/j.vascn.2023.107281_bb0220","first-page":"560","article-title":"Assessment of a 3D neural spheroid model to detect pharmaceutical-induced neurotoxicity","volume":"39","author":"Wang","year":"2022","journal-title":"ALTEX-Alternatives to Animal Experimentation"},{"key":"10.1016\/j.vascn.2023.107281_bb0225","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0006-8993(97)00585-4","article-title":"Mechanism of synchronized Ca2+ oscillations in cortical neurons","volume":"767","author":"Wang","year":"1997","journal-title":"Brain Research"},{"key":"10.1016\/j.vascn.2023.107281_bb0230","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.vascn.2008.01.004","article-title":"Validation of a larval zebrafish locomotor assay for assessing the seizure liability of early-stage development drugs","volume":"57","author":"Winter","year":"2008","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2023.107281_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0240991","article-title":"Screening for modulators of neural network activity in 3D human iPSC-derived cortical spheroids","volume":"15","author":"Woodruff","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.vascn.2023.107281_bb0240","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jphs.2021.12.006","article-title":"Electrophysiological responses to seizurogenic compounds dependent on E\/I balance in human iPSC-derived cortical neural networks","volume":"148","author":"Yokoi","year":"2022","journal-title":"Journal of Pharmacological Sciences"},{"key":"10.1016\/j.vascn.2023.107281_bb0245","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","article-title":"Index for rating diagnostic tests","volume":"3","author":"Youden","year":"1950","journal-title":"Cancer"},{"key":"10.1016\/j.vascn.2023.107281_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2021.115725","article-title":"Sensitivity, specificity and limitation of in vitro hippocampal slice and neuron-based assays for assessment of drug-induced seizure liability","volume":"430","author":"Zhai","year":"2021","journal-title":"Toxicology and Applied Pharmacology"}],"container-title":["Journal of Pharmacological and Toxicological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871923000321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871923000321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:08:33Z","timestamp":1761005313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056871923000321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":49,"alternative-id":["S1056871923000321"],"URL":"https:\/\/doi.org\/10.1016\/j.vascn.2023.107281","relation":{},"ISSN":["1056-8719"],"issn-type":[{"value":"1056-8719","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative assessment of Ca2+ oscillations in 2- and 3-dimensional hiPSC derived and isolated cortical neuronal networks","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological and Toxicological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vascn.2023.107281","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Merck Sharp & Dohme LLC., a subsidiary of Merck & Co., Inc., Rahway, NJ, USA and The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107281"}}